NOTICE OF INTENT TO SOLE SOURCE: CDC announces its intention to negotiate and issue a sole source award for the purchase of RNA Qualitative Aptima Kits and Reagents with Gen-Probe Inc.

The anticipated delivery date will be August 31, 2011. Gen-Probe Inc, is the only identified source that has FDA-approved kits for detecting HIV-1 RNA from human plasma specimens and can provide them within the timeframe deemed necessary. CDC intends to negotiate this requirement under the authority of FAR 13.106-1(b)(1). The sole source procurement will be awarded as a simplified acquisition in accordance with FAR Part 12 & FAR Subpart 13 procedures. The vendor will be responsible for the following supplying the following types for RNA Qualitative Aptima Kits and Reagents

20 - HIV-1 RNA QL Aptima Kits
6 - Aptima QL Auto Detect Reagents

This notice of intent is not a request for competitive proposals. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a capability statement demonstrating their abilities to meet this requirement. All responses should be received by August 24, 2011 at 12 PM Eastern Standard Time. All responses must be in writing and can be sent via email to [email protected]. No phone calls will be accepted.

Bid Protests Not Available